vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Knightscope, Inc. (KSCP). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.5M, roughly 1.5× Knightscope, Inc.). On growth, Knightscope, Inc. posted the faster year-over-year revenue change (-9.8% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 6.1%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Knightscope, Inc. is an American security camera and robotics company headquartered in Mountain View, California. Knightscope designs, builds and deploys robots called Autonomous Data Robots (ADRs) for use in monitoring people in malls, parking lots, neighborhoods and other public areas. Knightscope robots are fully autonomous using self-driving technology and are designed to alert police and security of incidents through sensors that detect weapons, read license plates and detect other suspi...

IRD vs KSCP — Head-to-Head

Bigger by revenue
IRD
IRD
1.5× larger
IRD
$3.9M
$2.5M
KSCP
Growing faster (revenue YoY)
KSCP
KSCP
+0.4% gap
KSCP
-9.8%
-10.2%
IRD
Faster 2-yr revenue CAGR
IRD
IRD
Annualised
IRD
50.3%
6.1%
KSCP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRD
IRD
KSCP
KSCP
Revenue
$3.9M
$2.5M
Net Profit
$-11.1M
Gross Margin
-63.8%
Operating Margin
-444.7%
Net Margin
-435.4%
Revenue YoY
-10.2%
-9.8%
Net Profit YoY
53.0%
-58.6%
EPS (diluted)
$-0.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
KSCP
KSCP
Q4 25
$3.9M
$2.5M
Q3 25
$3.1M
$3.1M
Q2 25
$2.9M
$2.7M
Q1 25
$4.4M
$2.9M
Q4 24
$4.3M
$2.8M
Q3 24
$3.9M
$2.5M
Q2 24
$1.1M
$3.2M
Q1 24
$1.7M
$2.3M
Net Profit
IRD
IRD
KSCP
KSCP
Q4 25
$-11.1M
Q3 25
$-17.5M
$-9.5M
Q2 25
$-7.4M
$-6.3M
Q1 25
$-8.2M
$-6.9M
Q4 24
$-7.0M
Q3 24
$-7.5M
$-10.9M
Q2 24
$-7.8M
$-6.3M
Q1 24
$-7.1M
$-7.6M
Gross Margin
IRD
IRD
KSCP
KSCP
Q4 25
-63.8%
Q3 25
-50.1%
Q2 25
-33.4%
Q1 25
-22.9%
Q4 24
-42.3%
Q3 24
-20.0%
Q2 24
-17.4%
Q1 24
-64.1%
Operating Margin
IRD
IRD
KSCP
KSCP
Q4 25
-444.7%
Q3 25
-269.9%
-303.7%
Q2 25
-309.0%
-228.0%
Q1 25
-227.2%
-234.1%
Q4 24
-245.1%
Q3 24
-207.1%
-305.4%
Q2 24
-748.9%
-211.1%
Q1 24
-450.5%
-367.3%
Net Margin
IRD
IRD
KSCP
KSCP
Q4 25
-435.4%
Q3 25
-566.9%
-304.7%
Q2 25
-257.5%
-230.2%
Q1 25
-187.5%
-236.4%
Q4 24
-247.7%
Q3 24
-194.6%
-430.1%
Q2 24
-698.3%
-195.8%
Q1 24
-415.3%
-336.8%
EPS (diluted)
IRD
IRD
KSCP
KSCP
Q4 25
$-0.84
Q3 25
$-0.25
$-0.98
Q2 25
$-0.12
$-0.90
Q1 25
$-0.24
$-1.28
Q4 24
$-0.72
Q3 24
$-0.29
$-3.58
Q2 24
$-0.30
$-2.68
Q1 24
$-0.29
$-3.99

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
KSCP
KSCP
Cash + ST InvestmentsLiquidity on hand
$45.1M
$20.6M
Total DebtLower is stronger
$4.0M
Stockholders' EquityBook value
$15.3M
$27.8M
Total Assets
$50.2M
$41.3M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
KSCP
KSCP
Q4 25
$45.1M
$20.6M
Q3 25
$30.8M
$20.4M
Q2 25
$32.4M
$8.2M
Q1 25
$41.8M
$12.7M
Q4 24
$30.3M
$11.1M
Q3 24
$36.6M
$5.2M
Q2 24
$41.4M
$2.6M
Q1 24
$47.2M
$2.5M
Total Debt
IRD
IRD
KSCP
KSCP
Q4 25
$4.0M
Q3 25
$4.0M
Q2 25
$4.0M
Q1 25
$4.0M
Q4 24
$4.0M
Q3 24
$3.9M
Q2 24
Q1 24
Stockholders' Equity
IRD
IRD
KSCP
KSCP
Q4 25
$15.3M
$27.8M
Q3 25
$6.0M
$26.9M
Q2 25
$17.5M
$15.1M
Q1 25
$5.1M
$18.2M
Q4 24
$6.7M
$15.8M
Q3 24
$34.3M
$9.3M
Q2 24
$40.6M
$11.2M
Q1 24
$46.1M
$-26.6M
Total Assets
IRD
IRD
KSCP
KSCP
Q4 25
$50.2M
$41.3M
Q3 25
$36.1M
$41.1M
Q2 25
$38.7M
$29.2M
Q1 25
$48.2M
$29.8M
Q4 24
$36.9M
$28.2M
Q3 24
$40.4M
$24.9M
Q2 24
$44.8M
$24.6M
Q1 24
$51.8M
$24.0M
Debt / Equity
IRD
IRD
KSCP
KSCP
Q4 25
0.14×
Q3 25
0.15×
Q2 25
0.26×
Q1 25
0.22×
Q4 24
0.25×
Q3 24
0.42×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
KSCP
KSCP
Operating Cash FlowLast quarter
$-35.3M
$-10.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
KSCP
KSCP
Q4 25
$-35.3M
$-10.6M
Q3 25
$-6.2M
$-7.9M
Q2 25
$-10.3M
$-5.5M
Q1 25
$-9.0M
$-6.4M
Q4 24
$-25.6M
$-5.1M
Q3 24
$-5.1M
$-4.7M
Q2 24
$-7.3M
$-4.0M
Q1 24
$-5.7M
$-8.6M
Free Cash Flow
IRD
IRD
KSCP
KSCP
Q4 25
Q3 25
$-8.1M
Q2 25
Q1 25
Q4 24
Q3 24
$-4.7M
Q2 24
Q1 24
FCF Margin
IRD
IRD
KSCP
KSCP
Q4 25
Q3 25
-258.7%
Q2 25
Q1 25
Q4 24
Q3 24
-187.1%
Q2 24
Q1 24
Capex Intensity
IRD
IRD
KSCP
KSCP
Q4 25
Q3 25
7.4%
Q2 25
Q1 25
Q4 24
Q3 24
0.3%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRD
IRD

Segment breakdown not available.

KSCP
KSCP

Emergency Communication Devices$1.5M60%
Other$1.0M40%

Related Comparisons